The heart valve specialist saw better-than-expected TAVR sales in the first quarter as hospitals addressed capacity ...

Edwards Lifesciences' first-quarter 2025 performance benefits from its differentiated portfolio of therapies to treat ...

This week’s Bulls N’ Bears ASX Runner of the Week is… Redstone Resources, which announced a biblically deep drill hole to ...

Anteris Technologies Global Corp.’s AVR share price has surged by 12.25%, which has investors questioning if this is right time to sell.

A new method of alerting clinical care providers holds promise for increasing treatment and improving survival for patients with severe aortic stenosis (AS), a valvular heart condition that can be ...

Dapagliflozin reduced the risk of death or worsening heart failure in older patients with aortic stenosis who underwent transcatheter aortic-valve implantation.

The 8-year data may hold value for TAVI—the newest Sapien valve uses the same tissue—but many other variables differ.

Compared with usual care, a system of electronic provider notification more often enabled patients diagnosed with severe ...

Blood enters the left ventricle through the mitral valve and leaves through the aortic valve. A stenotic valve is a valve opening that has gotten smaller and is partially obstructing blood flow. In ...

The company is rapidly expanding its interventional cardiology portfolio, and under the partnership will commercialize the ...

The material is employed in a range of Edwards’ surgical and transcatheter valves, including versions of the Inspiris, Mitris ...

Zydus Medtech, a subsidiary of Zydus Lifesciences, has entered into a global licensing agreement with Brazilian medical ...